Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Judson

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Sarcoma|April 7, 2010
Imaging of skeletal metastases in myxoid liposarcomaJ L Noble, E Moskovic, C Fisher, et al.
British Medical Journal (Clinical Research Ed.)|April 20, 1985
Nephrotic syndrome during treatment with interferonP Selby, J Kohn, J Raymond, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomasM Van Glabbeke, J Verweij, I Judson, et al.
Case Reports in Medicine|August 9, 2014
Reversion of Hormone Treatment Resistance with the Addition of an mTOR Inhibitor in Endometrial Stromal SarcomaJ Martin-Liberal, C Benson, C Messiou, et al.
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|September 1, 1990
Mussel culture and the accumulation of domoic acidG R Johnson, L Hanic, I Judson, et al.
The British Journal of Surgery|January 13, 2004
Gastrointestinal stromal tumours (Br J Surg 2003; 90: 1178- 1186)S J Neuhaus, M A Clark, J M Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2005
RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcomaP Therasse, A Le Cesne, M Van Glabbeke, et al.
British Journal of Cancer|January 1, 1997
Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistanceI Judson, E Briasoulis, F Raynaud, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 26, 2013
Multidisciplinary care of gastrointestinal stromal tumour: a review and a proposal for a pre-treatment classificationF C M Cananzi, I Judson, B Lorenzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Phosphoproteomics in translational research: a sarcoma perspectiveJ Noujaim, L S Payne, I Judson, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Sarcoma|April 7, 2010
Imaging of skeletal metastases in myxoid liposarcomaJ L Noble, E Moskovic, C Fisher, et al.
British Medical Journal (Clinical Research Ed.)|April 20, 1985
Nephrotic syndrome during treatment with interferonP Selby, J Kohn, J Raymond, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomasM Van Glabbeke, J Verweij, I Judson, et al.
Case Reports in Medicine|August 9, 2014
Reversion of Hormone Treatment Resistance with the Addition of an mTOR Inhibitor in Endometrial Stromal SarcomaJ Martin-Liberal, C Benson, C Messiou, et al.
Canada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|September 1, 1990
Mussel culture and the accumulation of domoic acidG R Johnson, L Hanic, I Judson, et al.
The British Journal of Surgery|January 13, 2004
Gastrointestinal stromal tumours (Br J Surg 2003; 90: 1178- 1186)S J Neuhaus, M A Clark, J M Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2005
RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcomaP Therasse, A Le Cesne, M Van Glabbeke, et al.
British Journal of Cancer|January 1, 1997
Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistanceI Judson, E Briasoulis, F Raynaud, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 26, 2013
Multidisciplinary care of gastrointestinal stromal tumour: a review and a proposal for a pre-treatment classificationF C M Cananzi, I Judson, B Lorenzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Phosphoproteomics in translational research: a sarcoma perspectiveJ Noujaim, L S Payne, I Judson, et al.
Pageof 12